Display options
Cite
Miller WR, Humeniuk V, Forrest AP. Factors affecting dehydroepiandrosterone sulphate levels in human breast secretions. Breast Cancer Res Treat. 1981;1(3):267-72doi: 10.1007/BF01806267.
Miller, W. R., Humeniuk, V., & Forrest, A. P. (1981). Factors affecting dehydroepiandrosterone sulphate levels in human breast secretions. Breast cancer research and treatment, 1(3), 267-72. https://doi.org/10.1007/BF01806267
Miller, W R, et al. "Factors affecting dehydroepiandrosterone sulphate levels in human breast secretions." Breast cancer research and treatment vol. 1,3 (1981): 267-72. doi: https://doi.org/10.1007/BF01806267
Miller WR, Humeniuk V, Forrest AP. Factors affecting dehydroepiandrosterone sulphate levels in human breast secretions. Breast Cancer Res Treat. 1981;1(3):267-72. doi: 10.1007/BF01806267. PMID: 6216932.
Copy Download .nbib Format: NLM
Share it on

Breast Cancer Res Treat. 1981;1(3):267-72. doi: 10.1007/BF01806267.

Factors affecting dehydroepiandrosterone sulphate levels in human breast secretions.

Breast cancer research and treatment

W R Miller, V Humeniuk, A P Forrest

PMID: 6216932 DOI: 10.1007/BF01806267

Abstract

Human breast secretions as collected by nipple aspiration have been analysed for dehydroepiandrosterone sulphate by radioimmunoassay. All secretions collected from non-lactating normal women contained remarkably high levels of dehydroepiandrosterone sulphate as compared with plasma taken at the same time. Although there was a large range of concentrations, levels were of a similar magnitude in different ducts from the same breast and in different breasts from the same individual. No significant difference was detected between secretions from pre and postmenopausal women. Sequential sampling of breast secretions through the menstrual cycle in two normal premenopausal women showed no cyclic variation in dehydroepiandrosterone sulphate concentration. There was also no significant difference between levels in breast secretions obtained from normal women and patients with either malignant or benign breast disease. Analysis of secretions from tumour and non-tumour bearing breasts in cancer patients failed to show consistent differences although, in contrast to normal women, the variation between breasts in individual patients was often marked.

References

  1. Eur J Cancer. 1974 Aug;10(8):477-82 - PubMed
  2. Eur J Cancer. 1976 Dec;12 (12 ):951-8 - PubMed
  3. J Endocrinol. 1968 Dec;42(4):567-78 - PubMed
  4. Lancet. 1977 Dec 3;2(8049):1179 - PubMed
  5. Cancer Res. 1981 Jan;41(1):105-7 - PubMed
  6. J Clin Endocrinol Metab. 1974 Aug;39(2):340-6 - PubMed
  7. Steroids. 1979 Sep;34(3):249-58 - PubMed
  8. J Invest Dermatol. 1973 Mar;60(3):121-5 - PubMed
  9. Lancet. 1977 Oct 22;2(8043):840-2 - PubMed
  10. Eur J Cancer. 1977 Jan;13(1):43-7 - PubMed
  11. Biochem J. 1970 Mar;116(5):919-21 - PubMed
  12. J Steroid Biochem. 1980 Feb;13(2):145-51 - PubMed
  13. J Natl Cancer Inst. 1975 Apr;54(4):829-34 - PubMed
  14. Acta Endocrinol (Copenh). 1966;52:Suppl 109:1-67 - PubMed

Substances

MeSH terms

Publication Types